Skip to main content
News Hölzel 01.2022
© Roberta Turiello

News categories: Publication

Tumor Cell Plasticity in Therapy Resistance

Prof. Dr. Michael Hölzel, Member of the Cluster of Excellence ImmunoSensation2 at the University of Bonn receives project funding of 1.5 million euros provided by the German Cancer Aid.

Cancer cells can constantly change and in this way evade the immune system. Prof. Dr. Michael Hölzel from the Institute of Experimental Oncology at the University of Bonn is developing an immunotherapy against black skin cancer: He wants to use "smart" immune cells to get a grip on the tumor cells that are currently trying to make themselves invisible. German Cancer Aid is funding the project with 1.5 million euros over the next five years as part of its new "Excellence Funding Program for Established Scientists".

Malignant melanoma (black skin cancer) originates from the pigment-forming melanocytes in the skin. "Melanocytes are very important for us to protect our skin and body from the harmful effects of UV radiation," says Prof. Dr. Michael Hölzel, director of the Institute of Experimental Oncology at the University Hospital Bonn. "One characteristic of melanoma is that it tends to metastasize to different sites inside the body early on." Additionally, melanoma cells are able to evade detection and hence elimination by T Cells by changing their molecular appearance. A key goal of Hölzel’s research is to understand the molecular mechanisms that orchestrate tumor cell plasticity. "For many years, together with other research teams, we have been investigating which influences change the appearance of melanoma cells - these include, for example, inflammatory signals in the tumor tissue," says Hölzel.

Cancer cells also change during the course of immunotherapy and evade the immune system. In the project funded by the German Cancer Aid, Hölzel wants to adjust the immunotherapy accordingly, so that its effectiveness lasts longer. Further, the scientist wants to investigate the phenomenon of various differing melanoma cells arising spontaneously, exhibiting a plethora of different surface features. "In the project, we are looking into the question of whether pure chance also plays a role in this - as if the dice decides which characteristics a melanoma cell has," says the Hölzel. If this is the case, how does such molecular dicing work? How may new therapies like tumor vaccines be made less vulnerable to the power of chance?

In recent years, there has been progress in trying to make the immune system "sharp" against black skin cancer tumor cells. "But only a portion of patients benefit, and the disease often comes back," Hölzel says. "This means there is a great need for better therapies that are smarter than the tumor, so to speak."

Michael Hölzel is a member of the Cluster of Excellence "ImmunoSensation2" and the Transdisciplinary Research Units "Mathematics, Modeling and Simulation of Complex Systems" and "Life and Health" at the University of Bonn.

As part of its new "Excellence Funding Program for Established Scientists", German Cancer Aid is funding a total of six particularly innovative, but also "daring" projects ('High Risk - High Gain'). "In this way, we would like to give researchers the necessary financial and time freedom to implement trend-setting ideas for the prevention, diagnosis and treatment of cancer and to break new ground conceptually," says Gerd Nettekoven, Chairman of the Board of German Cancer Aid. "We see this as an opportunity for a substantial gain in knowledge and the potential to decisively advance cancer medicine."

Source: Press release of German Cancer Aid


Contact

Prof. Dr. Michael Hölzel

Direktor des Instituts für Experimentelle Onkologie

Universitätsklinikum Bonn

Tel. +49-228-28712170

E-Mail: Michael.Hoelzel@ukbonn.de

Related news

News_Lukacs-Kornek

News categories: Publication

Obesity causes lungs to age prematurely

What effects does severe obesity have on the lungs? A research team led by Prof. Dr. Veronika Lukacs-Kornek from the ‘ImmunoSensation2’ Cluster of Excellence at the University of Bonn and the Institute for Molecular Medicine and Experimental Immunology (IMMEI) at the University Hospital Bonn (UKB) investigated this question. The results suggest that obesity causes the lungs to age faster. The findings have been published in the journal ‘Cell Reports’.
View entry
filamentous actin structures in T cells

News categories: Publication

How Cell Skeleton Defects Can Teach Immunology

For immune cells, the actin cytoskeleton is more than a structural scaffold. Immune cells can migrate to sites of infection or form precise, short-lived contacts with other cells, by constantly reshaping their actin cytoskeleton. Genetic errors in the molecular machinery controlling actin dynamics lead to impaired immunity, and often to autoimmunity and chronic inflammation. An overview of the current state of research on immune-related actinopathies, prepared by scientists arround ImmunoSensation² member Prof. Kaan Boztug, has now been published in Nature Reviews Immunology.
View entry
Wachten lab

News categories: Publication

Fat cells under false command

Too much fat can be unhealthy: how fat cells, so-called adipocytes, develop, is crucial for the function of the fat tissue. That is why a team led by researchers from the University Hospital Bonn (UKB) and the University of Bonn investigated the influence of primary cilia dysfunction on adipocyte precursor cells in a mouse model. They found that overactivation of the Hedgehog signaling pathway causes abnormal development into connective tissue-like cells instead of white fat cells. Their findings have now been published in The EMBO Journal.
View entry

Back to the news overview